UnitedHealth Group Incorporated $UNH Shares Sold by First Hawaiian Bank

Key Points

• First Hawaiian Bank significantly reduced its stake in UnitedHealth Group by 96.7%, owning only 453 shares after selling over 13,000 shares in the first quarter.
• Several large investors have altered their positions in the company, with notable increases from Bayforest Capital Ltd and Clal Insurance Enterprises Holdings Ltd, indicating a shift in investment strategies among institutions.
• UBS Group reaffirmed a "buy" rating for UnitedHealth Group, while analysts have varied target prices, with the average target set at $358.95.

First Hawaiian Bank reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 96.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 453 shares of the healthcare conglomerate's stock after selling 13,324 shares during the quarter. First Hawaiian Bank's holdings in UnitedHealth Group were worth $237,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in UNH. Bayforest Capital Ltd raised its stake in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares during the last quarter. Copia Wealth Management acquired a new position in shares of UnitedHealth Group in the fourth quarter worth $42,000. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the first quarter worth $42,000. Finally, Investment Management Corp VA ADV acquired a new position in shares of UnitedHealth Group in the fourth quarter worth $44,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research reports. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Wolfe Research cut their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a report on Tuesday, May 20th. Truist Financial raised their target price on UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a report on Tuesday, September 9th. JPMorgan Chase & Co. cut their target price on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a report on Wednesday, August 6th. Finally, Baird R W downgraded UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $358.95.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $348.05 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The firm has a 50 day moving average of $292.87 and a 200-day moving average of $367.43. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $315.22 billion, a P/E ratio of 15.08, a price-to-earnings-growth ratio of 2.30 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the firm earned $6.80 EPS. The business's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group's payout ratio is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.